Document is current

Any future updates will be listed below

A non-controlled, single arm, open label, phase II study of intravenous and intratumoral administration of ParvOryx in patients with metastatic, inoperable pancreatic cancer: ParvOryx02 protocol

Crossref DOI link: https://doi.org/10.1186/s12885-017-3604-y

Published Online: 2017-08-29

Published Print: 2017-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark